Human Ipsc-Derived Midbrain Dopaminergic Neurons For Parkinsons Disease Modeling And Cell Therapy

Human iPSC-derived Midbrain Dopaminergic Neurons for Parkinson’s Disease Modeling and Cell Therapy

Fujifilm Cellular Dynamics

Dustin Wakeman Advancing PD Cell Therapy Transplanting Cryopreserved iPSC derived Neurons

Using iCell DopaNeurons in Parkinson's Disease Research

Fujifilm Cellular Dynamics

Using iPS cell technology to model human neurodegenerative diseases

Thermo Fisher Scientific

3D Organoid Models for Differentiation of PSC-Derived Dopaminergic Neurons

Thermo Fisher Scientific

Autologous iPSC Based Cell Therapy for Parkinson’s Disease

3-D Organoid Models for Differentiation of PSC-Derived Dopaminergic Neurons

The Promise and Challenges of iPSC Modeling in Parkinson’s Disease

Fujifilm Cellular Dynamics

Processing iPS cells to make dopamine neurons

Oxford Parkinson's Disease Centre

Reversing a Model of Parkinson's Disease with In Situ Converted Nigral Neurons

University of California Television (UCTV)

Cell Based Approaches to Treating Parkinson's Disease

HMS Center for Bioethics

Modelling disorders of the brain through patient-derived stem cells

Thermo Fisher Scientific

Advanced Models of Parkinson’s Disease Webinar

American Type Culture Collection

Using Human iPSC-derived Cell-Types in Novel Functional Assays, Disease Modeling and Drug Discovery

Fujifilm Cellular Dynamics

Birgitt Schuele- Birgitt Schuele - Promise and challenges of iPSC modeling in Parkinson’s disease

IPS cell-derived dopaminergic neurons function in primate Parkinson’s disease model: Figures 2a-c

Addressing the scalability of human iPSC-derived neurons for HTS implementation

WFNS YNF WEbinar - Prof Jeff Schweitzer - Progenitor Cells for Parkinson’s Disease

WFNS Young Neurosurgeons Forum

GMP-compliant hESC-derived dopaminergic neurons

BioLamina - Revolutionizing cell culture

Dr. Birgitt Schuele, ISSCR 2013 -- Generating Parkinson's Disease models

Thermo Fisher Scientific